These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 18689384

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Partial neutralization of the acidogenic Western diet with potassium citrate increases bone mass in postmenopausal women with osteopenia.
    Jehle S, Zanetti A, Muser J, Hulter HN, Krapf R.
    J Am Soc Nephrol; 2006 Nov; 17(11):3213-22. PubMed ID: 17035614
    [Abstract] [Full Text] [Related]

  • 5. Potassium Citrate Supplementation Decreases the Biochemical Markers of Bone Loss in a Group of Osteopenic Women: The Results of a Randomized, Double-Blind, Placebo-Controlled Pilot Study.
    Granchi D, Caudarella R, Ripamonti C, Spinnato P, Bazzocchi A, Massa A, Baldini N.
    Nutrients; 2018 Sep 12; 10(9):. PubMed ID: 30213095
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy of a combined alendronate and calcitriol agent (Maxmarvil®) in Korean postmenopausal women with early breast cancer receiving aromatase inhibitor: a double-blind, randomized, placebo-controlled study.
    Rhee Y, Song K, Park S, Park HS, Lim SK, Park BW.
    Endocr J; 2013 Sep 12; 60(2):167-72. PubMed ID: 23064476
    [Abstract] [Full Text] [Related]

  • 8. Combined bioavailable isoflavones and probiotics improve bone status and estrogen metabolism in postmenopausal osteopenic women: a randomized controlled trial.
    Lambert MNT, Thybo CB, Lykkeboe S, Rasmussen LM, Frette X, Christensen LP, Jeppesen PB.
    Am J Clin Nutr; 2017 Sep 12; 106(3):909-920. PubMed ID: 28768651
    [Abstract] [Full Text] [Related]

  • 9. Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial.
    Cheung AM, Tile L, Lee Y, Tomlinson G, Hawker G, Scher J, Hu H, Vieth R, Thompson L, Jamal S, Josse R.
    PLoS Med; 2008 Oct 14; 5(10):e196. PubMed ID: 18922041
    [Abstract] [Full Text] [Related]

  • 10. Effects of a Multispecies Probiotic Supplement on Bone Health in Osteopenic Postmenopausal Women: A Randomized, Double-blind, Controlled Trial.
    Jafarnejad S, Djafarian K, Fazeli MR, Yekaninejad MS, Rostamian A, Keshavarz SA.
    J Am Coll Nutr; 2017 Oct 14; 36(7):497-506. PubMed ID: 28628374
    [Abstract] [Full Text] [Related]

  • 11. Oral daily ibandronate prevents bone loss in early postmenopausal women without osteoporosis.
    McClung MR, Wasnich RD, Recker R, Cauley JA, Chesnut CH, Ensrud KE, Burdeska A, Mills T, Oral Ibandronate Study Group.
    J Bone Miner Res; 2004 Jan 14; 19(1):11-8. PubMed ID: 14753731
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of odanacatib on BMD and safety in the treatment of osteoporosis in postmenopausal women previously treated with alendronate: a randomized placebo-controlled trial.
    Bonnick S, De Villiers T, Odio A, Palacios S, Chapurlat R, DaSilva C, Scott BB, Le Bailly De Tilleghem C, Leung AT, Gurner D.
    J Clin Endocrinol Metab; 2013 Dec 14; 98(12):4727-35. PubMed ID: 24064689
    [Abstract] [Full Text] [Related]

  • 18. Long-term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in elderly women.
    Riggs BL, O'Fallon WM, Muhs J, O'Connor MK, Kumar R, Melton LJ.
    J Bone Miner Res; 1998 Feb 14; 13(2):168-74. PubMed ID: 9495509
    [Abstract] [Full Text] [Related]

  • 19. Supplementation with calcium and short-chain fructo-oligosaccharides affects markers of bone turnover but not bone mineral density in postmenopausal women.
    Slevin MM, Allsopp PJ, Magee PJ, Bonham MP, Naughton VR, Strain JJ, Duffy ME, Wallace JM, Mc Sorley EM.
    J Nutr; 2014 Mar 14; 144(3):297-304. PubMed ID: 24453130
    [Abstract] [Full Text] [Related]

  • 20. Long-term consumption of isoflavone-enriched foods does not affect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: a randomized, double-blind, placebo controlled study.
    Brink E, Coxam V, Robins S, Wahala K, Cassidy A, Branca F, PHYTOS Investigators.
    Am J Clin Nutr; 2008 Mar 14; 87(3):761-70. PubMed ID: 18326616
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.